Drug Target Discovery
21 – 30 of 274
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner.
(
- Contribution to journal › Article
-
Mark
Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load
(
- Contribution to journal › Article
-
Mark
17 beta-Estradiol induces nongenomic effects in renal intercalated cells through G protein-coupled estrogen receptor 1
(
- Contribution to journal › Article
- 2011
-
Mark
G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling
(
- Contribution to journal › Scientific review
-
Mark
Serum gastrin and gastric enterochromaffin-like cells during estrous cycle, pregnancy and lactation, and in response to estrogen-like agents in rats
(
- Contribution to journal › Article
-
Mark
G Protein-Coupled Estrogen Receptor 1 (GPER1)/GPR30 Localizes in the Plasma Membrane and Trafficks Intracellularly on Cytokeratin Intermediate Filaments.
(
- Contribution to journal › Article
-
Mark
Textile Dyes Disperse Orange 1 and Yellow 3 Contain More Than One Allergen As Shown by Patch Testing with Thin-Layer Chromatograms
(
- Contribution to journal › Article
-
Mark
Insulinotropic and Antidiabetic Effects of 17{beta}-Estradiol and the GPR30 Agonist G-1 on Human Pancreatic Islets.
(
- Contribution to journal › Article
-
Mark
The GPER1 Agonist G-1 Attenuates Endothelial Cell Proliferation by Inhibiting DNA Synthesis and Accumulating Cells in the S and G2 Phases of the Cell Cycle.
(
- Contribution to journal › Article
-
Mark
New topics in bradykinin research.
(
- Contribution to journal › Article